Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Illuminating Patient Selection for PBM in AMD: A Case-Based Discussion
October 10, 2026 New Orleans, Louisiana
Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs
Ashkan Abbey, MD
Rishi Singh, MD, FASRS
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Why Staging TED Correctly Matters Even When CAS Is Low
Kimberly Cockerham, MD
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Michael A. Klufas, MD
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Overcoming Real-World Barriers to TED Treatment
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP
Jaclyn Kovach, MD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.